- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03455010
Dose-Response Relationship of Ambulatory Load and Cartilage - Pilot Study (COMP)
The research question is if there is a dose-response relationship between blood biomarkers for articular cartilage and the magnitude of physiological load. To investigate this load induced biomarker change, the participants will complete a 30-minute walking test under three loading conditions: A: 80%, B: 100% C: 120% of their respective bodyweight (Fig. 1).
The main biomarker we are interested in is called cartilage oligomeric matrix protein (COMP). Serum COMP levels are increased immediately after 30-min running but there is no dose-response relationship shown yet.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The current state of research in the field and of our own research clearly shows that the in vivo mechanobiology of articular cartilage is poorly understood. Previous results of changes in cartilage biomarker concentrations after ambulatory exercise raise the following question:
Do load-induced changes in blood biomarkers for articular cartilage (COMP) depend on the physiological load magnitude? To generate initial data for answering this question, we will establish the experimental framework to systematically study the in vivo mechanobiology of human articular cartilage to address the following aims.
- To obtain pilot data for investigating the in vivo dose-response relationship of weight-bearing and blood levels of mechanosensitive biomarker of articular cartilage using controlled load- bearing as experimental paradigm.
- To provide pilot data for comparing ambulatory biomechanics between the controlled load- bearing conditions.
The experimental setting consists of a 30-minutes walking stress test under three loading conditions: A: 80 %, B: 100% and C: 120% bodyweight. Unloading will be achieved through an unloading system and additional loading with an adjustable weight vest. Before and after the walking stress test, venous blood samples will be taken at five time points. The biomarker concentration is measured with a commercial available enzyme-linked immunosorbent assay (ELISA).
Hypothesis Our working hypothesis is that there is a dose-response relationship between the temporarily increased or decreased load and the load-induced change in COMP level in the blood serum. We assume that serum COMP concentration increases with increasing accumulated load on the knee cartilage simulated through the three different loading conditions.
Design The design of the pilot study is a controlled multimodal data collection (biological, biomechanical) with block randomization. Specifically, we will collect blood samples and biomechanical (kinematic and pressure) data. We will determine the relationship between the serum blood concentration and the biomechanical data.
Because this is a cross-over study, all participants will perform the same three walking stress tests but in random order. Each participant of the study will be tested for 2.5 hours on 3 separate days.
Method In this experiment, we will test 24 healthy participants (12 male, 12 female) on 3 test days under three different loading conditions in a randomized block design. On each test day, participants will complete walking stress test for 30-minutes with A: 80%, B: 100% and C: 120% of their bodyweight. Through the modified bodyweight we generate higher or lower forces on the knee cartilage, which should affect the COMP concentration in the blood serum.
To measure the change in serum COMP concentration, blood samples will be taken at five time points before and after the walking stress test. The blood samples are taken by a study nurse. For the venipuncture, a thin, sterile, disposable vein catheter is placed in the antecubital vein. The catheter stays in the vein for the entire 2.5 hours of the experiment. Blood samples will be collected and allowed to clot for 30-minutes. Serum will be separated and frozen in aliquots to -20°C within 1 hour of collection and then transferred for storage at -80°C until assayed. Serum biomarker concentrations will be determined using commercial ELISAs.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Basel Stadt
-
Basel, Basel Stadt, Suisse, 4031
- University Hospital Basel
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age between 18 and 30 years
- being physically active (> 2/week)
- body mass index (BMI) <30 kg/m2
Exclusion Criteria:
- previous knee injury
- neuromuscular condition affecting gait
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: Normal load
Healthy subjects walking for 30 minutes on a treadmill with normal body weight
|
|
|
Expérimental: Increased load
Healthy subjects walking for 30 minutes on a treadmill with 20% additional body weight
|
Participants walk with 120% body weight achieved with a weight vest
|
|
Expérimental: Reduced load
Healthy subjects walking for 30 minutes on a treadmill with 20% lower body weight
|
Participants walk with 80% body weight achieved by a dynamic unloading system
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Load-induced serum Cartilage Oligomeric Matrix Protein concentration
Délai: 3 hours
|
Change in serum concentration during 30-minute walking exercise determined by commercial ELISA 30 min before to 2 hours after 30-minute walking exercise
|
3 hours
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Overall ground reaction force impulse
Délai: 30 minutes
|
Area under the ground reaction curve multiplied by number of steps taken during 30-minute walking exercise
|
30 minutes
|
|
Dynamic range of motion lower extremity joints
Délai: 30 minutes
|
Min to max joint angles (ankle, knee, hip) measured using RehaGait (inertial measurement units)
|
30 minutes
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Age
Délai: At enrollment
|
Age in years
|
At enrollment
|
|
Sex
Délai: At enrollment
|
male or female
|
At enrollment
|
|
Body mass index
Délai: At enrollment
|
BMI in kg/m2
|
At enrollment
|
|
Knee function
Délai: At enrollment
|
Knee Osteoarthritis Outcome Score measured by questionnaire (best score: 100 - no limitations; worst score: 0)
|
At enrollment
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Annegret Muendermann, PhD, University Hospital, Basel, Switzerland
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 2017-01006
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur En bonne santé
-
AstraZenecaParexelComplété
Essais cliniques sur Increased load
-
Johns Hopkins UniversityCepheidPas encore de recrutement
-
Udayana UniversityPas encore de recrutementReconstruction du ligament croisé antérieur | Formation sur la restriction du flux sanguin | Morphologie musculaire | Position de rotule | Fonction de jambeIndonésie
-
Columbia UniversityNational Institute on Aging (NIA)Recrutement
-
Macfarlane Burnet Institute for Medical Research...RecrutementHépatite CAustralie